Oncolytics Biotech Statistics
Total Valuation
ONCY has a market cap or net worth of $63.82 million. The enterprise value is $50.92 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ONCY has 77.07 million shares outstanding. The number of shares has increased by 17.93% in one year.
Current Share Class | n/a |
Shares Outstanding | 77.07M |
Shares Change (YoY) | +17.93% |
Shares Change (QoQ) | +1.22% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 75.76M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | 9.52 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.12.
Current Ratio | 2.99 |
Quick Ratio | 2.57 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -145.20% and return on invested capital (ROIC) is -111.57%.
Return on Equity (ROE) | -145.20% |
Return on Assets (ROA) | -62.89% |
Return on Capital (ROIC) | -111.57% |
Revenue Per Employee | n/a |
Profits Per Employee | -$705,557 |
Employee Count | 29 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ONCY has paid $111,033 in taxes.
Income Tax | 111,033 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.56% in the last 52 weeks. The beta is 1.51, so ONCY's price volatility has been higher than the market average.
Beta (5Y) | 1.51 |
52-Week Price Change | -36.56% |
50-Day Moving Average | 1.04 |
200-Day Moving Average | 1.04 |
Relative Strength Index (RSI) | 41.85 |
Average Volume (20 Days) | 437,833 |
Short Selling Information
Short Interest | 2.29M |
Short Previous Month | 2.60M |
Short % of Shares Out | 3.89% |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.51 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -26.20M |
Pretax Income | -20.29M |
Net Income | -20.46M |
EBITDA | -26.12M |
EBIT | -26.20M |
Earnings Per Share (EPS) | -$0.27 |
Full Income Statement Balance Sheet
The company has $14.51 million in cash and $787,594 in debt, giving a net cash position of $13.72 million or $0.18 per share.
Cash & Cash Equivalents | 14.51M |
Total Debt | 787,594 |
Net Cash | 13.72M |
Net Cash Per Share | $0.18 |
Equity (Book Value) | 6.70M |
Book Value Per Share | 0.09 |
Working Capital | 11.29M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$18.69 million and capital expenditures -$174,692, giving a free cash flow of -$17.73 million.
Operating Cash Flow | -18.69M |
Capital Expenditures | -174,692 |
Free Cash Flow | -17.73M |
FCF Per Share | -$0.23 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |